We are live on ! Find out more
TLSI icon

TriSalus Life Sciences
TLSI

60 hedge funds and large institutions have $44.6M invested in TriSalus Life Sciences in 2025 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 18 increasing their positions, 11 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

650% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 2

64% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 11

25% more funds holding

Funds holding: 48 → 60 (+12)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

5% less capital invested

Capital invested by funds: $46.8M → $44.6M (-$2.25M)

3.48% less ownership

Funds ownership: 22.7% → 19.22% (-3.5%)

Holders
60
Holders Change
+12
Holders Change %
+25%
% of All Funds
0.79%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
15
Increased
18
Reduced
11
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.62M
2
BlackRock
BlackRock
New York
+$778K
3
Goldman Sachs
Goldman Sachs
New York
+$626K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$465K
5
State Street
State Street
Massachusetts
+$361K

Top Sellers

Rank Fund Capital Flow
1
GGHC
Gilder Gagnon Howe & Co
New York
-$215K
2
Morgan Stanley
Morgan Stanley
New York
-$180K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$112K
4
Deutsche Bank
Deutsche Bank
Germany
-$105K
5
UBS Group
UBS Group
Switzerland
-$36.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
CAPTRUST Financial Advisors
26
CAPTRUST Financial Advisors
North Carolina
$101K +$102K +21,827 New
N
27
Nuveen
North Carolina
$95.8K – – –
SFA
28
Sequoia Financial Advisors
Ohio
$90.5K +$91.1K +19,456 New
Cambridge Investment Research Advisors
29
Cambridge Investment Research Advisors
Iowa
$90K – – –
New York State Common Retirement Fund
30
New York State Common Retirement Fund
New York
$84.1K -$7.98K -1,705 -9%
Morgan Stanley
31
Morgan Stanley
New York
$83.6K -$180K -38,351 -68%
RhumbLine Advisers
32
RhumbLine Advisers
Massachusetts
$69.9K -$6.73K -1,438 -9%
Wells Fargo
33
Wells Fargo
California
$68.1K +$18.2K +3,878 +36%
UBS Group
34
UBS Group
Switzerland
$41.7K -$36.1K -7,714 -46%
Mirae Asset Global ETFs Holdings
35
Mirae Asset Global ETFs Holdings
Hong Kong
$40.3K -$145 -31 -0.4%
JP Morgan Chase
36
JP Morgan Chase
New York
$35K -$89 -19 -0.3%
PFSRSONJ
37
Police & Firemen's Retirement System of New Jersey
New Jersey
$25.1K – – –
BNP Paribas Financial Markets
38
BNP Paribas Financial Markets
France
$22.2K +$8.24K +1,759 +58%
AAP
39
Arax Advisory Partners
Colorado
$18.8K +$187 +40 +1%
TRCT
40
Tower Research Capital (TRC)
New York
$14K +$13.6K +2,915 +2,974%
Russell Investments Group
41
Russell Investments Group
United Kingdom
$12.7K +$12.8K +2,729 New
AIP
42
Ameritas Investment Partners
Nebraska
$7.58K – – –
Legal & General Group
43
Legal & General Group
United Kingdom
$6.76K – – –
SCM
44
Sterling Capital Management
North Carolina
$4.64K +$3.09K +659 +194%
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$4.64K +$5 +1 +0.1%
WAM
46
Wolverine Asset Management
Illinois
$3.81K +$908 +194 +31%
HRC
47
Hoertkorn Richard Charles
$3.11K – – –
AB
48
Amalgamated Bank
New York
$3K – – –
JFG
49
JDM Financial Group
Texas
$2.46K – – –
Royal Bank of Canada
50
Royal Bank of Canada
Ontario, Canada
$2K -$2.82K -602 -63%
1
2
3

TLSI Hedge Fund Activity: Q3 2025 in Review

60 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences (TLSI) for Q3 2025, worth a combined $44.6M — down 4.8% from $46.8M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new TLSI positions and 2 closed out — a net gain of 13 holders — while 18 added to existing stakes and 11 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.62M. The largest seller was Gilder Gagnon Howe & Co, cutting an estimated $215K.

  • 60 institutional investors held TriSalus Life Sciences (TLSI) as of Q3 2025, up from 48 in Q2 2025.
  • Funds reported $44.6M of TriSalus Life Sciences stock for Q3 2025, down 4.8% quarter-over-quarter.
  • 15 funds opened new TriSalus Life Sciences positions in Q3 2025 and 2 closed out, a net change of +13 holders.
  • The largest TriSalus Life Sciences buyer in Q3 2025 was Vanguard Group, an estimated $1.62M added.
  • The largest TriSalus Life Sciences seller in Q3 2025 was Gilder Gagnon Howe & Co, an estimated $215K sold.

Based on aggregated 13F filings for Q3 2025.